| TCID | Name | Organismal Type | Example |
|---|---|---|---|
| 2.A.6.1: The Heavy Metal Efflux (HME) Family | |||
|
2.A.6.1.1 | Heavy metal (Ni2 and Co2 ) efflux pump, CnrA. Functions with CnrB (TC# 8.A.1.2.1) and CnrC (TC# 1.B.17.2.1) (Grass et al. 2000; Tibazarwa et al. 2000). | Gram-negative bacteria | CnrA of Cupriavidus (Ralstonia; Alcaligenes) metallidurans (eutrophus or eutropha) (P37972) |
|
2.A.6.1.2 | Gram-negative bacteria | CzcA/CzcB of Cupriavidus (Ralstonia; Alcaligenes) metallidurans (eutriphus or eutropha) CzcA (P13511) CzcB (P13510) | |
|
2.A.6.1.3 | Gram-negative bacteria | SilA of Salmonella typhimurium | |
|
2.A.6.1.4 | Cu+ /Ag+ efflux pump, CusABCF (may pump ions from the periplasm to the external medium); CusF is a periplasmic Cu+ /Ag+ binding receptor essential for full resistance (Franke et al., 2003). Bagai et al. (2007) reported that CusB (MFP) binds one molecule of Ag+ or Cu+ via four conserved methionines and induces a substrate-linked conformational change (Bagai et al., 2007). The crystal structures of CusB are available (Su et al., 2009). The crystal structure of the CusAB complex has been solved (PDB# 3K07) (Su et al., 2011a). CusC is listed under TC# 1.B.17.3.5. The metal-binding methionines play a role in restricting the substrates to monovalent heavy metals (Conroy et al., 2010). It has been reported to export L-cysteine (Yamada et al., 2006). Crystal structures of the CusA efflux pump suggested that methionine residues in a 3-methionine cluster, bind the metal as a transport intermediate (Long et al., 2010). Four methionine pairs in the transmembrane region, and one in the periplasmic domain may comprise the channel. Cu+ is exported from the cytoplasm to the extracellular space. The Cus efflux system removes Cu+ and Ag+ from both the cell cytoplasm and the periplasm via a "methionine shuttle" (Su et al., 2011b). | Gram-negative bacteria | CusCFBA of E. coli: CusA (RND) CusB (MFP) CusC (OMF) (see 1.B.17.3.5) CusF (BP) |
|
2.A.6.1.5 |
The Zn2+, Cd2+, Pb2+ exporter, CzcCBA1 (induced by Zn2+, Cd2+, Pb2+, Ni2+, Co2+ and Hg2+ (Leedjarv et al., 2007)) | Bacteria | CzcCBA1 of Pseudomonas putida CzcA1 (RND) (Q88RT6) CzcB1 (MFP) (Q88RT5) CzcC1 (OMF) (Q88RT4) |
|
2.A.6.1.6 | The Zn2+-specific exporter, ZneABC. The ZneB MFP plays an active role in substrate efflux through metal binding and release. Its 2.8 Å structure is available (De Angelis et al., 2010). | Proteobacteria | ZneABC of Cupriavidus (Ralstonia) metallidurans (eutrophus or eutropha) ZneC (DMF) (Q1LCD9) ZneA (RND) (Q1LCD8) ZneB (MFP) (Q1LCD7) |
|
2.A.6.1.7 | δ-Proteobacteria | Cus1ABC of Myxococcus xanthus Cus1A (RND) (Q1DDM9) Cus1B (MFP) (Q1DDM8) Cus1C (OMF) (Q1DDM7) | |
|
2.A.6.1.8 | δ-Proteobacteria | Cus2ABC of Myxococcus xanthus Cus2A (RND) (Q1DDM4) Cus2B (MFP) (Q1DDM3) Cus2C (OMF) (Q1DDM2) | |
|
2.A.6.1.9 | Putative heavy metal (Me2+) exporter, Czc1ABC (induced by heavy metals, but not Cu2+; Moraleda-Muñoz et al., 2010) | α-Proteobacteria | Czc1ABC of Myxococcus xanthus Czc1A (RND) (Q1D6S7) Czc1B (MFP) (Q1D6S8) Czc1C (OMF) (Q1D6S9) |
|
2.A.6.1.10 | Putative Cu2+ exporter, Czc2ABC. (induced by Cu2+ and other heavy metal ions; Moraleda-Muñoz et al., 2010) | δ-Proteobacteria | Czc2AB of Myxococcus xanthus Czc2A (RND) (Q1D665) Czc2B (MFP) (Q1D664) |
|
2.A.6.1.11 | δ-Proteobacteria | Czc3ABC of Myxococcus xanthus Czc3A (RND) (Q1CVN2) Czc3B (MFP) (Q1CVN1) Czc3C (OMF) (Q1CVN0) | |
|
2.A.6.1.12 | Gram-negative bacteria | NccABC of Alcaligenes xylosoxidans NccA (RND) (Q44586) NccB (MFP) (Q44585) NccC (OMF) (Q44584) | |
|
2.A.6.1.13 | Gram-negative bacteria | CzrABC of Pseudomonas aeruginosa CzrA (RND) (Q9RLI8) CzrB (MFP) (Q9RLI9) CzrC (OMF) (Q9RLJ0) | |
|
2.A.6.1.14 | CznABC Cd2+, Zn2+, Ni2+ resistance efflux pump. Required for urea modulation and gastric colonization (Stähler et al., 2006). | Gram-negative bacteria | CznABC of Helicobacter pylori CznA (RND) (O25622) CznB (MFP) (O25623) CznC (OMF) (O25624) |
|
2.A.6.1.15 | Bacteria | CzrCBA of Caulobacter crescentus NA1000 CzrA (RND) (B8H146) CzrB (MFP) (B8H144) CzrC (OMF) (B8H143) | |
|
2.A.6.1.16 | Bacteria | NczCBA of Caulobacter crescentus NA1000 NczA (RND) (B8GZE9) NczB (MFP) (B8GZE8) NczC (OMF) (B8GZE7) | |
|
2.A.6.1.17 | Proteobacteria | ZniA of Cupriavidus metallidurans | |
|
2.A.6.1.18 | Proteobacteria | NimA of Cupriavidus metallidurans | |
| 2.A.6.2: The (Largely Gram-negative Bacterial) Hydrophobe/Amphiphile Efflux-1 (HAE1) Family | |||
|
2.A.6.2.1 | Multidrug (acriflavin, doxorubicin, ethidium, rhodamine 6G, SDS, deoxycholate) resistance pump [required for normal chromosomal condensation and segregation as well as cell division] (Lau and Zgurskaya, 2005). Exports L-cysteine (Yamada et al., 2006). | Gram-negative bacteria | AcrEF (EnvCD) of E. coli AcrE (MFP) (P24180) AcrF (EnvD) (RND) (P24181) |
|
2.A.6.2.2 | Multidrug/dye/detergent/bile salt/organic solvent resistance pump (substrates include: chloramphenicol, tetracycline, erythromycin, nalidixic acid, fusidic acid, fluoroquinolones, lipophilic β-lactams, norfloxacin, doxorubicin, novobiocin, rifampin, trimethoprim, acriflavin, crystal violet, ethidium, disinfectants rhodamine-6G, TPP, benzalkonium, SDS, Triton X-100, deoxycholate/bile salts/organic solvents (alkanes), growth inhibitory steroid hormones (estradiola and progesterone), and phospholipids) (Elkins and Mullis, 2006) (Lateral entry of substrate from the lipid bilayer into AcrB and its homologues has been proposed.) (Yu et al., 2003a; 2003b) [Asymmetric trimer structure: Seeger et al., 2006]. Structure of a complex with YajC known (Törnroth-Horsefield et al., 2007). A covalently linked trimer of AcrB provides evidence for a peristaltic pump, alternative access, rotation mechanism (Takatsuka and Nikaido, 2009;Nikaido and Takatsuka, 2009; Pos, 2009) Further evidence for a rotatory mechanisms stems from kinetic analyses for cephalosporin efflux which can exhibit positive cooperativity (Nagano and Nikaido, 2009). May also export signaling molecules for cell-cell communication (Yang et al., 2006). The substrates may be captured in the lower cleft region of AcrB, then transported through the binding pocket, the gate and finally to the AcrB funnel that connects AcrB to TolC (Husain & Nikaido et al., 2010). | Gram-negative bacteria | AcrAB of E. coli AcrA (MFP) (P31223) AcrB (RND) (P31224) |
|
2.A.6.2.3 | Gram-negative bacteria | IfeB of Agrobacterium tumefaciens | |
|
2.A.6.2.4 |
The multidrug resistance pump, AdeDE (exports amikacin, ceftazidime, chloramphenicol, ciprofloxacin, erythromycin, ethidium bromide, meropenem, rifampin, and tetracycline) (Chau et al., 2004). | Gram negative bacteria | AdeDE of Acinetobacter sp. 4356
AdeD (Q67GM1) AdeE (Q8GKU1) |
|
2.A.6.2.5 | Fatty acid, bile salt, gonadal steroid, antibacterial peptide efflux pump, MtrCDE (Kamal et al., 2007). Opening of the outer membrane protein channel, MtrE, in the tripartite efflux pump, MtrCDE, is induced by interaction with the membrane fusion partner, MtrC (Janganan et al., 2011). | Gram-negative bacteria | MtrCDE of Neisseria gonorrhoeae: MtrC (MFP) (P43505) MtrD (RND) (Q51073) MtrE (OMF) (Q51006) |
|
2.A.6.2.6 | Multiple drug; N-(3-oxododecanoyl)- L-homoserine lactone autoinducer efflux pump, MexB (functions with MexA (an MFP, 8.A.1) and OprM (an OMF, 1.B.17; see 2.A.6.2.21). All three interact with each other. MexA promotes assembly and stability of the complex (Nehme and Poole, 2007)). Exports β-lactams, fluoroquinolones, tetracycline, macrolides, chloramphenicol, biocides, and a toxic indole compound, CBR-4830, that targets the MreB actin (Robertson et al., 2007). Confers tolerance to tea tree oil and its monoterpene components Terpinen-4-ol, 1,8-cineole and α-terpineol (Papadopoulos et al., 2008) as well as the antimicrobial peptide, colistin (Pamp et al., 2008) (Mao et al., 2002; Poole, 2008). The crystal structure has been solved at 3.0Å resolution (Sennhauser et al., 2009). The MexA-OprM complex has an elongated cylindrical appearance (Trépout et al., 2010). Mutations affecting export of antibiotics with cytoplasmic targets have been identified (Ohene-Agyei et al. 2012). | Gram-negative bacteria | MexAB of Pseudomonas aeruginosa MexA (P52477) MexB (P52002) |
|
2.A.6.2.7 | Multidrug efflux pump, AcrD (exports aminoglycosides (amikacin, gentamicin, neomycin, kanamycin and tobramycin) as well as anionic detergents (SDS and deoxycholate) and growth inhibitory steroid hormones (estradiol and progesterone)(Elkins and Mullis, 2006)) (exports aminoglycosides from the periplasm as well as the cytoplasm) (Aires and Nikaido, 2005). (Also contributes to copper and zinc resistance; regulation is mediated by BaeSR, and indole, Cu2+ and Zn2+ induce (Nishino et al., 2007)). Exports L-cysteine (Yamada et al., 2006). | Gram-negative bacteria | AcrD of E. coli (P24177) |
|
2.A.6.2.8 | Gram-negative bacteria | ArpB of Pseudomonas putida | |
|
2.A.6.2.9 |
Solvent efflux pump, TtgABC (extrudes toluene, styrene, m-xylene, ethylbenzene and propylbenzene) (Teran et al., 2007). | Gram-negative bacteria | TtgABC of Pseudomonas putida: TtgA (Q9WWZ9) TtgB (O52248) TtgC (Q9WWZ8) |
|
2.A.6.2.10 |
Solvent efflux pump, TtgDEF (extrudes only toluene and styrene) (Teran et al., 2007). | Gram-negative bacteria | TtgDEF of Pseudomonas putida: TtgD (Q9KWV5) TtgE (Q9KWV4) TtgF (Q9KWV3) |
|
2.A.6.2.11 |
Solvent and antibiotic efflux pump, TtgGHI (SrpABC) (Kieboom et al. 1998; Terán et al., 2007) (solvents extruded include toluene, styrene, m-xylene, ethylbenzene and propylbenzene) (Teran et al., 2007). TtgGHI is the same as SrpABC (Kieboom et al., 1998) | Gram-negative bacteria | TtgGHI of Pseudomonas putida TtgG (Q93PU5) TtgH (Q93PU4) TtgI (Q93PU3) |
|
2.A.6.2.12 | Heteromeric multidrug/detergent resistance protein YegN/YegO (MdtB/MdtC) of E. coli (exports nalidixic acid, norfloxacin, cloxicillin, enoxacin, kanamycin, benzalkonium, bile salts, SDS and deoxycholate). It forms a complex with MdtA (an MFP, TC# 8.A.1.6.2). Drug resistance depends on the simultaneous presence of all three proteins (Baranova and Nikaido, 2002). (Also contributes to copper and zinc resistance; regulation is mediated by BaeSR, and indole, Cu2 and Zn2 induce (Nishino et al., 2007)). MdtB:C stoichiometry = 2:1; MdtB and MdtC may play different roles (Kim et al., 2010), MdtB transporting the proton and MdtC transporting the drug (Kim and Nikaido 2012). | Bacteria | MdtB/MedtC of E. coli MdtB (YegN) (P76398) MdtC (YegO) (P76399) |
|
2.A.6.2.13 |
Multidrug/dye/detergent resistance protein, YhiV or MdtF (exports erythromycin, doxorubicin, crystal violet, ethidium, rhodamine 6G, TPP, benzalkonium, SDS, deoxycholate and growth inhibitory steroid hormones (estradiol and progesterone)(Elkins and Mullis, 2006)) | Bacteria | YhiV of E. coli |
|
2.A.6.2.14 | SmeVWX MDR efflux pump. Drugs include chloramphenicol, quinolones, tetracyclines and aminoglycosides, but not β-lactams and erythromycin (Chen et al., 2011). | Proteobacteria | SmeVWX of Stenotrophomonas maltophilia SmeV (MFP) (B2FLY3) SmeW (RND) (B2FLY4) SmeX (OMF) (B2FLY6) |
|
2.A.6.2.15 |
Multidrug efflux pump, MexD (exports β-lactams, fluoroquinolones, tetracycline, macrolides, chloramphenicol, biocides, including levofloxacin, carbenicillin, aztreonam, ceftazidime, cefepime, cefoperazone, piperacillin, erythromycin, azithromyein, chloramphenicol, etc.; Mao et al., 2002). Functions with MexC (MFP) and OprJ (OMF) (Mao et al., 2002; Poole, 2008). | Bacteria | MexD of Pseudomonas aeruginosa |
|
2.A.6.2.16 |
Multidrug efflux pump, MexF (exports fluoroquinolones, chloramphenicol, biocides, xenobiotics and chloramphenicol; functions with MexE (MFP) and OprN (OMF)) (Kohler et al., 1997; Poole, 2008) | Bacteria | MexF of Pseudomonas aeruginosa (AAG05882) |
|
2.A.6.2.17 |
Multidrug efflux pump, MexK (exports fluoroquinolones, tetracycline, macrolides, chloramphenicol; biocides, and triclosan [with MexJ but without OprM] as well as tetracycline, erythromycin [requiring both MexJ and OprM]; Chuanchuen et al., 2002). Can function with OpmH (BAC24099) instead of OprM (Poole, 2008). | Bacteria | MexK of Pseudomonas aeruginosa |
|
2.A.6.2.18 |
The polycyclic aromatic hydrocarbon (phenanthrene; anthacene; fluoranthene)/drug (chloramphenicol; naldixic acid) exporter, EmhABC (Hearn et al., 2003; 2006) | Bacteria | EmhABC of Pseudomonas fluorescens EmhA (Q6V6X9) EmhB (Q6V6X8) EmhC (Q6V6X7) |
|
2.A.6.2.19 |
The multidrug efflux pump, EefABC (exports chloramphenicol, ciprofloxacin, erythromycin, tetracycline and doxycycline) (Masi et al., 2005). EefC exhibits low ionic selectivity (Masi et al., 2007). | Bacteria | EefABC of Enterobacter aerogenes EefA (MFP) (Q8GC84) EefB (RND) (Q8GC83) EefC (OMF) (Q8GC82) |
|
2.A.6.2.20 |
The toxoflavin (a phytotoxin) exporter, ToxGHI (Kim et al., 2004) | Bacteria | ToxGHI of Burkholderia glumae ToxG (MFP) (AAV52812) ToxH (RND) (AAV52813) ToxI (OMF) (AAV52814) |
|
2.A.6.2.21 | The multidrug (aminoglycosides, β-lactams, fluoroquinolones, macrolides, chloramphenicol, tetracycline, erythromycin, ofloxacin, etc.) efflux pump, MexXY-OprM (Jeannot et al., 2005) | Gram-negative bacteria | MexXY-OprM of Pseudomonas aeruginosa MexX, BAA34299 MexY, BAA34300 OprM, Q51487 |
|
2.A.6.2.22 |
The conjugated and unconjugated bile (bile-inducible)/multidrug (ethidium, ciprofloxacin, norfloxacin, tetracycline, cefotaxime, rifampicin, erythromycin, chloramphenicol, salicylate; drug-noninducible) efflux pump (Lin et al., 2005) | Bacteria | CmeABC of Campylobacter jejuni CmeA (MFP) (AAL74244) CmeB (RND) (AAL74245) CmeC (OMF) (AAL74246) |
|
2.A.6.2.23 |
The multidrug (β-lactams, aminoglycerides (gentamycin and streptomycin) macrolides (erythromycin) and dye (acriflavin)) efflux pump, BpeAB-OprB (Chan et al., 2004; Chan and Chua, 2005). It also exports acyl homoserine lactones including N-octanoyl-homoserine lactone, N-decanoyl-homoserine lactone, N-(3-hydroxy)-octanoyl-homoserine lactone, N-(3-hydroxy)-decanoyl-homoserine lactone, N-(3-oxo)-decanoyl-homoserine lactone, and N-(3-oxo)-tetradecanoyl-homoserine lactone (Chan et al., 2007). | Gram-negative bacteria | BpeAB-OprB of Burkholderia pseudomallei BpeA (MFP) (AAQ94109) BpeB (RND) (AAQ94110) OprB (OMF) (AAQ94111) |
|
2.A.6.2.24 |
The multidrug (aminoglycosides (e.g., streptomycin, gentamycin, neomycin, tobramycin, kanamycin and spectinomycin) and macrolides (e.g., erythromycin and clarithromycin, but not lincosamide and clindamycin)) efflux pump, AmrAB-OprA (Moore et al., 1999) | Gram-negative bacteria | AmrAB-OprA of Burkholderia pseudomallei AmrA (MFP) AAC27753 AmrB (RND) AAC27754 OprA (OMF) |
|
2.A.6.2.25 | The gold (Au2+) resistance efflux pump, GesABC (induced by GolS in the presence of Au2+; also mediates drug resistance when induced by Au2+ (Pontel et al., 2007). Also exports a variety of organic chemicals including chloramphenicol (Conroy et al., 2010). | Bacteria | GesABC of Salmonella enterica GesA (MFP) (Q8ZRG8) GesB (RND) (Q8ZRG9) GesC (OMF) (Q8ZRH0) |
|
2.A.6.2.26 |
The multidrug efflux pump, VmeAB-VpoC (Matsuo et al., 2007). | Bacteria | VmeAB-VpoC of Vibrio parahaemolyticus: VmeA (MFP) (Q2AAU4) VmeB (RND) (Q2AAU3) VpoC (OMF) (Q87SJ8) |
|
2.A.6.2.27 |
The Triclosan resistance efflux pump TriABC-OpmH (the only known RND pump requiring two MFPs) (Mima et al., 2007) | Bacteria | TriABC-OpmH of Pseudomonas aeruginosa TriA (MFP) (Q9I6X6) TriB (MFP) (Q9I6X5) TriC (RND) (Q9I6X4) OpmH (OMF) (Q9HUJ1) |
|
2.A.6.2.28 | Proteobacteria | AcrAB of Francisella tularensis AcrA (A4KT88) AcrB (A7YV33) | |
|
2.A.6.2.29 |
The AdeIJK MDR pump (contributes to resistance to β-lactams, chloramphenicol, tetracycline, erythromycin, lincosamides, fluoroquinolines, fusidic acid, tigecycline, novobiocin, rifampin, trimethoprim, acridine, safranin, pyronine, and sodium dodecyl sulfate) (Damier-Piolle et al., 2008) | Bacteria | AdeIJK of Acinetobacter baumannii AdeI (MFP) (Q2FD95) AdeJ (RND) (Q24LT7) AdeK (OMF) (Q24LT6) |
|
2.A.6.2.30 |
VexEF-TolC mediates resistance to various antimicrobials; ethidium efflux is Na+-dependent (Rahman et al., 2007) | Gram-negative bacteria | VexEF / TolC of Vibrio cholerae VexE (MFP) (A6P7H2) VexF (RND) (A6P7H3) TolC (OMF) (Q9K2Y1) |
|
2.A.6.2.31 |
Multidrug efflux pump, SdeAB-HasF (mediates fluoroquinolone efflux) (Begic and Worobec, 2008) (HasF is > 60% identical to TolC of E. coli (1.B.17.1.1)) | Gram-negative bacteria | SdeAB-HasF of Serratia marcescens SdeA (MFP) (Q79MP5) SdeB (RND) (Q84GI9) HasF (OMF) (Q6GW09) |
|
2.A.6.2.32 |
Multidrug efflux pump, MexHI OpmD (exports fluoroquinolones; Poole, 2008). | Bacteria | MexHI OpmD of Pseudomonas aeruginosa MexH (MFP) (Q9HWH5) MexI (RND) (Q9HWH4) OpmD (OMF) (Q9HWH3) |
|
2.A.6.2.33 |
Multidrug efflux pump, MexVW OmpM (exports fluoroquinolones, microlides, chloramphenicol, and tetracycline) (Poole, 2008). | Bacteria | MexW of Pseudomonas aeruginosa MexW (RND) (Q9HW27) |
|
2.A.6.2.34 |
Multidrug efflux pump, MexPQ-OpmE; export fluoroquinolones, tetracycline, macrolides and chloramphenicol (Poole, 2008) | Bacteria | MexPQ-OpmE of Pseudomonas aeruginosa MexP (MFP) (Q9HY86) MexQ (RND) (Q4LDT6) OpmE (OMF) (Q9HY88) |
|
2.A.6.2.35 |
Multidrug efflux pump, MexMN-OprM; exports chloramphenicol (Poole, 2008) | Bacteria | MexMN-OprM of Pseudomonas aeruginosa MexM (MFP) (Q9I3R2) MexN (RND) (Q4LDT8) |
|
2.A.6.2.36 | Bacteria | VexB of Vibrio cholerae (Q9KVI2) | |
|
2.A.6.2.37 | Bacteria | VexD of Vibrio cholerae (A6P7H1) | |
|
2.A.6.2.38 | Bacteria | VexK of Vibrio cholerae (Q9KRG9) | |
|
2.A.6.2.39 | THe MuxABC-OpmB multidrug (aztreonam, macrolides, novobiocin and tetracycline) resistance efflux pump complex (with two RND-type proteins (MuxB and MuxC)), both required for activity (Mima et al., 2009). | Bacteria | MuxABC-OpmB complex of Pseudomonas aeruginosa MuxA (MFP) (PA2528) (Q9I0V5) MuxB (RND) (PA2527) (Q9I0V6) MuxC (RND) (PA2526) (Q9I0V7) OpmB (OMF) (Q9I0V8) |
|
2.A.6.2.40 | MDR pump, AdeABC. Exports chloramphenicol and tetracycline (Hassan et al., 2011). | Bacteria | AdeABC of Acinetobacter baumannii AdeA (MFP) (Q2FD71) AdeB (RND) (Q2FD70) AdeC (OMF) (Q2FD69) |
|
2.A.6.2.41 | SmeABC MDR efflux pump. Drugs include Ciprofloxacin (Cho et al., 2012). | Proteobacteria | SmeABC of Stenotrophomonas maltophilia SmeA (MFP) (Q9RBY9) SmeB (RND) (Q9RBY8) SmeC (OMF) (Q9RBY7) |
|
2.A.6.2.42 | SmeDEF MDR efflux pump. Mediates resistance to a wide range of drugs including ethidium bromide and norfloxacin (Alonso and Martínez, 2000). Regulated by SmeT and activated by insertion of the transposon, IS1246 (Gould and Avison, 2006). | Proteobacteria | SmeDEF of Stenotrophomonas maltophilia SmeD (MFP) (Q9F241) SmeE (RND) (Q9F240) SmeF (OMF) (Q9F239) |
|
2.A.6.2.43 | Multidrug resistance pump, SmeJK. Shown to export teracycline, minocycline, ciprofloxacin and levofloxacin (Gould et al., 2012). | Bacteria | SmeJK of Stenotrophomonas maltophilia D457 SmeJ (I0KTJ0) SmeK (I0KTJ1) |
|
2.A.6.2.44 | Multidrug efflux pump, AdeFGH. Mediates high level resistance to chloramphenicol, clindamycin, fluoroquinolones, and trimethoprim and decreased susceptibility to tetracycline-tigecycline and sulfonamides; susceptibility to β-lactams, erythromycin, aminoglycosides and rifampin was not affected. It also mediates increased resistance to ethidium bromide, safranin O, acridine orange, trimethoprim and sulfamethoxazole (Coyne et al. 2010). | γ-Proteobacteria | AdeFGH of Acinetobacter baumannii AdeF (MFP) (Q2FD82) AdeG (RND) (Q2FD81) AdeH (OMF) (Q2FD80) |
| 2.A.6.3: The Putative Nodulation Factor Exporter (NFE) Family | |||
|
2.A.6.3.1 | Putative lipooligosaccharide nodulation factor exporter, NolG (1065 aas; previously thought to be 3 ORFs, NolGHI, an artifact due to sequencing errors and consequent frameshifting (Baev et al. 1991; Ardourel et al. 1994). | Gram-negative bacteria | NolG of Rhizobium meliloti (P25197) |
|
2.A.6.3.2 | α-Proteobacteria | NolG of Agrobacterium tumefaciens (A9CGX6) | |
|
2.A.6.3.3 | γ-Proteobacteria | NolG of Acinetobacter baumanii (E8PBU7) | |
|
2.A.6.3.4 | δ-Proteobacteria | NolG of Myxococcus xanthus (Q1DEX6) | |
|
2.A.6.3.5 | Cyanobacteria | NolG of Synechococcus sp. PCC7335 (B4WH09) | |
|
2.A.6.3.6 | Firmicutes | NolG of Oceanobacillus iheyensis (Q8CX78) | |
|
2.A.6.3.7 | δ-Proteobacteria | Cus3ABC of Myxococcus xanthus Cus3A (RND) (Q1CZ65) Cus3B (MFP) (Q1CZ64) Cus3C (OMF) (Q1CZ66) | |
|
2.A.6.3.8 | Efflux pump for antifungal and antibacterial syringopeptin and syringmycin lipodepsipeptides (see 1.D.35) as well as acriflavin, erythromycin and tetracycline, PseABC (Kang and Gross 2005). | Proteobacteria | PseABC of Pseudomonas syringae PseA (OMF) (L8NE56) PseB (MFP) (L8NGR5) PseC (RND) (L8NFZ8) |
| 2.A.6.4: The SecDF (SecDF) Family | |||
|
2.A.6.4.1 | The secretory accessory proteins, SecDF. The first periplasmic domain of SecDF has been crystallized (Echizen et al., 2011). SecDF appears to function as a pmf-driven H+ transporter that functions as a chaperone to achieve ATP-dependent protein translocation (Tsukazaki et al., 2011). | Bacteria | SecDF of E. coli; SecD; SecF |
|
2.A.6.4.2 | Bacteria | SecDF of Bacillus subtilis | |
|
2.A.6.4.3 | Bacteria | SecDF of Thermus thermophilus | |
| 2.A.6.5: The (Gram-positive Bacterial Putative) Hydrophobe/Amphiphile Efflux-2 (HAE2) Family | |||
|
2.A.6.5.1 | The antibiotic actinorhodin transport-associated protein, ActII3 | Gram-positive bacteria | ActII3 of Streptomyces coelicolor |
|
2.A.6.5.2 | The phthiocerol dimycocerosate (PDIM) lipid exporter, MmpL7. Also confers high level isoniazid efflux and resistance (Pasca et al., 2005). | Gram-positive bacteria | MmpL7 of Mycobacterium tuberculosis ( P65370) |
|
2.A.6.5.3 | The putative glycopeptidolipid exporter, TmtpC (most similar to MmpL of M. leprae; implicated in sliding motility). May function with the MmpS4 protein of Mucobacterium smegmatis (A0QPN7) to form a scaffold for coupled biosynthesis and transport (Deshayes et al., 2010). | Gram-positive bacteria | TmtpC of Mycobacterium smegmatis |
|
2.A.6.5.4 | sulfolipid, 2,3-diacyl-α, α'-D-trehalose-2'-sulfate (sulfatide precursor) exporter, MmpL8 (Domenech et al., 2004; Seeliger et al. 2012Seeliger et al. 2012). | Gram-positive bacteria | MmpL8 of Mycobacterium tuberculosis (CAB10022) |
|
2.A.6.5.5 | Mycobacterial heme acquisition system, Rv0202c - Rv0207c. Takes up free heme and heme from hemoglobin as an iron source. May function with Rv0206c (MmpL3; TC#2.A.6.5.6) and Rv0202c (Tullius et al., 2011). However, see description of MmpL3 (2.A.6.5.6) | Actinobacteria | Heme uptake system of Mycobacterium tuberculosis MmpL11 (P65374) |
|
2.A.6.5.6 | MmpL3 (Rv0206; 944 aas) May function with MmpL11 (TC# 2.A.6.5.5) (Tullius et al., 2011). MmpL3 exports trehalose monomycolate, involved in mycolic acid donation to the cell wall core (Tahlan et al., 2012). SQ109, a 1,2,-diamine related to ethambutol is an inhibitor of MmpL3 (Tahlan et al., 2012). | Bacteria | MmpL3 of Mycobacterium tuberculosis (O53657) |
|
2.A.6.5.7 | Siderophore export transporter, MmpL4 (Wells et al. 2013). Functions with MmpS4 (TC#8.A.35.1.1) which is essential for transport activity. MmpL4/MmpS4 and MmpL5/MmpS5 (TC# 2.A.6.5.8 and TC# 8.A.35.1.2, respectively) are two siderophore exporters that overlap in function (Wells et al. 2013). | Actinobacteria | MmpL4 of Mycobacterium tuberculosis |
|
2.A.6.5.8 | Siderophore exporter, MmpL5. Functions with MmpS5, and both proteins are essential for transport activitiy (Wells et al. 2013). | Actinobacteria | MmpL5 of Mycobacterium tuberculosis |
| 2.A.6.6: The Eukaryotic (Putative) Sterol Transporter (EST) Family | |||
|
2.A.6.6.1 | Niemann-Pick C1 AND C2 disease proteins together may form a lipid/cholesterol exporter from lysosomes to other cellular sites (Sleat et al., 2004). NPC1 deficiency causes lysosomal retention of cholesterol, sphingolipids, phospholipids, and glycolipids (Infante et al. 2008 a). NPC1 binds cholesterol, 25-hydroxycholesterol and various oxysterols (Infante et al. 2008 b; Liu et al., 2009 ). Soluble NPC2 binds cholesterol, and then passes it to the N-terminal domain of membranous NPC1 (Abi-Mosleh et al., 2009). Cholesterol trafficking in Niemann-Pick C-deficient cells is reviewed by Peake and Vance (2010). | Animals | NPC1 and NPC2 of Homo sapiens NPC1 (AAH63302) NPC2 (AAH02532) |
|
2.A.6.6.2 | Animals | "Patched" of Drosophila melanogaster | |
|
2.A.6.6.3 | Protein, yeast | YPL006w of Saccharomyces cerevisiae | |
|
2.A.6.6.4 | Animals | SCAP of Cricetulus griseus | |
|
2.A.6.6.5 | Animals | HMG-CoA reductase of Homo sapiens | |
|
2.A.6.6.6 | Liver/intestinal enterocyte brush border Niemann-Pick C1 like 1 (NPC1L1) protein; responsible for ezetimibe-sensitive absorption of luminal lipids and cholesterol via a transport mechanism (Altmann et al., 2004; Davies et al., 2005; Liscum, 2007, Dixit et al. 2007). NPC1L1-dependent sterol uptake seems to be a clathrin-mediated endocytic process and is regulated by cellular cholesterol content (Betters and Yu, 2010; Jia et al., 2011). Dietary cholesterol induces trafficking of the intestinal NPC1L1 from the brush boarder to endosomes (Skov et al. 2011). It distributes on the brush border membranes of enterocytes and the canalicular membranes of hepatocytes. It is the target of ezetimibe, a hypocholesterolemic drug which blocks internalization of NPC1L1 and cholesterol in the mouse small intestine (Wang and Song 2012; Xie et al. 2012). | Animals | NPC1L1 of Homo sapiens (NP_037521) |
|
2.A.6.6.7 | Slime molds | NPC of Dictyostelium discoideum (Q9TVK6) | |
|
2.A.6.6.8 | Animals | Ncr-1 of Caenorhabditis elegans (Q19127) | |
|
2.A.6.6.9 | Animals | Ncr-2 of Caenorhabditis elegans (P34389) | |
| 2.A.6.7: The (Largely Archaeal Putative) Hydrophobe/Amphiphile Efflux-3 (HAE3) Family | |||
|
2.A.6.7.1 | Gene AF1229 | Archaea | ORF in Archaeoglobus fulgidus |
|
2.A.6.7.2 | Archaea | ORF in Methanococcus jannaschii | |
|
2.A.6.7.3 | Proteobacteria | HAE3 family member of Myxococcus xanthus | |
|
2.A.6.7.4 | Proteobacteria | HAE3 family member of Myxococcus xanthus | |
|
2.A.6.7.5 | Hopanoid biosynthesis associated RND transporter like protein, HpnN. Required for hopanoid localization to the outer membrane (Doughty et al. 2011). | α-Proteobacteria | Putative hopanoid transporter of Rhodopseudomonas palustris |
|
2.A.6.7.6 | Planctomycetes | RND exporter of Rhodopirellula baltica | |
| 2.A.6.8: The Brominated, Aryl Polyene Pigment Exporter (APPE) Family | |||
|
2.A.6.8.1 | Xanthomonadin (brominated, aryl polyene pigment) exporter (to its outer membrane site), ORF4 | Bacteria | ORF4 in the pig (pigment) gene locus of Xanthomonas oryzae pv. oryzae |
|
2.A.6.8.2 | γ-Proteobacteria | RND transporter of E. coli | |
| 2.A.6.9: The Dispatched (Dispatched) Family | |||
|
2.A.6.9.1 | Dispatched, putative exporter of the cholesterol-modified peptide, hedgehog; sterol sensor protein (Ma et al., 2002). Loss prevents hedgehog signaling. (Nakano et al., 2004; Higgins, 2007). | Animals | Dispatched of Drosophila melanogaster (AAF_23397) |
|
2.A.6.9.2 | Animals | Disp1 of Mus musculus | |
